Davis Polk
Samantha Lefland
- Deals
- 3
- Latest
- Jun 2026
Firm
- Davis Polk Law firm · 2026 · 3 deals
Often works with
- David R. Bauer 3 deals together
- Matthew Yeowart 2 deals together
- Michael Mollerus 2 deals together
- Veronica M. Wissel 2 deals together
- William A. Curran 1 deal together
- Jesse Solomon 1 deal together
- Meytal McCoy 1 deal together
- Andrzej O’Leary 1 deal together
Deals
Deals dated after 30 September 2026 are still being collected.
Columns
| Jun 2026 | SAGA Diagnostics | – | Roche | Acquisition | Legal adviser to Roche (acquirer) | Announced | 595.0 | Diagnostics+1 | Roche acquisition of SAGA Diagnostics |
| May 2026 | PathAI | – | Roche | Acquisition | Legal adviser to Roche (acquirer) | Pending | 750.0 | Healthcare Software+2 | Roche acquisition of PathAI |
| Jan 2026 | AbelZeta's 50% share of China development and commercialisation rights to C-CAR031 | AbelZeta | AstraZeneca | Asset sale | Legal adviser to AbelZeta (target) | Announced | 630.0 | Biotech+2 | AstraZeneca acquisition of AbelZeta's 50% share of China development and commercialisation rights to C-CAR031 |
Deals where Samantha Lefland is named on the firm's deal team, by the firm or the press.